Intraperitoneal disease control after i.p. consolidation treatment with Yttrium-90-labeled HMFG1 monoclonal antibody in patients with epithelial ovarian cancer

LFAG Massuger; RHM Verheijen; MW Seiden; BB Benigno; JT Soper; A. Lopes; J. Markowska; R Vyzula; AA Epenetos

Intraperitoneal disease control after i.p. consolidation treatment with Yttrium-90-labeled HMFG1 monoclonal antibody in patients with epithelial ovarian cancer

LFAG Massuger, RHM Verheijen, MW Seiden, BB Benigno, JT Soper, A. Lopes, J. Markowska, R Vyzula, AA Epenetos

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Pages	929
Publication status	Published - 2005
Event	SGO - Miami, United States Duration: 19 Mar 2005 → 23 Mar 2005

Conference

Conference	SGO
Country/Territory	United States
City	Miami
Period	19/03/05 → 23/03/05

Cite this

@conference{31a2aa4526c1490fbb61125ffa2bec62,

title = "Intraperitoneal disease control after i.p. consolidation treatment with Yttrium-90-labeled HMFG1 monoclonal antibody in patients with epithelial ovarian cancer",

author = "LFAG Massuger and RHM Verheijen and MW Seiden and BB Benigno and JT Soper and A. Lopes and J. Markowska and R Vyzula and AA Epenetos",

year = "2005",

language = "English",

pages = "929",

note = "SGO ; Conference date: 19-03-2005 Through 23-03-2005",

}

TY - CONF

T1 - Intraperitoneal disease control after i.p. consolidation treatment with Yttrium-90-labeled HMFG1 monoclonal antibody in patients with epithelial ovarian cancer

AU - Massuger, LFAG

AU - Verheijen, RHM

AU - Seiden, MW

AU - Benigno, BB

AU - Soper, JT

AU - Lopes, A.

AU - Markowska, J.

AU - Vyzula, R

AU - Epenetos, AA

PY - 2005

Y1 - 2005

M3 - Abstract

SP - 929

T2 - SGO

Y2 - 19 March 2005 through 23 March 2005

ER -